DVA logo

DVA DaVita Inc.

New York Stock Exchange · Medical - Care Facilities · Healthcare

$161.03
+4.69 (+3.00%)

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own d…

Market Cap: $10.13Bwww.davita.com

Price

No data yet.

Social Signal Score

57
5d
—
30d
57
15 mentions
—
60d
57
27 mentions
—
90d
58
36 mentions
—
news: 30 · rss: 6

Analyst Ratings

23 analysts
Holdconsensus
Strong Buy 0Buy 10Hold 12Sell 1Strong Sell 0
Avg price target$238.5+48.1%
Low $215Median $222High $287
Current Consensus

Revenue

$3.58B-3.70%
$2.74B$3.14B$3.53B$3.92B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$10.56
$10.50–$10.61
4 analysts
FY2026
$14.83+40% YoY
$14.66–$15.15
4 analysts
FY2027
$16.71+13% YoY
$15.73–$17.74
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Javier J. Rodriguez
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
78,000
Beta
0.86
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
1.65
www.davita.com